New Brunswick extends restrictions and limits use of Oxford-AstraZeneca vaccine

·1 min read

FREDERICTON — Health officials reported 11 new cases of COVID-19 in the Edmundston region of northwestern New Brunswick Monday and expanded the area under the red level of their pandemic response plan.

The province imposed a "circuit-breaker" last week in a portion of the Edmundston region, and the restrictions have now been extended to the rest of the region, with the exception of the Saint-Quentin and Kedgwick areas.

Red-level restrictions include a ban on travel in and out of the affected area, a limit on gatherings to members of a household and the closure of restaurant dining rooms and recreation facilities.

Mass testing of 3,335 asymptomatic people in the Edmundston region on Thursday and Friday resulted in three positive results.

There are now 114 active cases of COVID-19 in the province and four patients are hospitalized, including two in intensive care.

As a result of a recommendation from the National Advisory Committee on Immunization, New Brunswick will pause the use of the Oxford-AstraZeneca COVID-19 vaccine in people under the age of 55.

The province will continue to use it among older age groups.

This report by The Canadian Press was first published Mar. 29, 2021.

The Canadian Press